Kitov Pharmaceuticals

$4.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.23%) Today
+$0.01 (+0.23%) As of 8:31 AM EDT after-hours

Why Robinhood?

You can buy or sell KTOV and other stocks, options, and ETFs commission-free!

About KTOV

Kitov Pharma Ltd. American Depositary Shares, also called Kitov Pharmaceuticals, is a development stage pharmaceutical company, which engages in drug development. Read More It operates through two segments: Oncology, and Pain & Hypertension. The Oncology segment includes NT219, a therapeutic candidate which is a small molecule that targets two signal transduction pathways which are involved in the development of cancer drug resistance mechanisms, and which is currently in the late pre-clinical stage of development. The Pain & Hypertension segment includes Consensi, a combination drug for the simultaneous treatment of two clinical conditions, pain caused by osteoarthritis and hypertension (high blood pressure), which can be pre-existing or caused by the treatment for osteoarthritis. The company was founded by John Paul Waymack in June 2010 and is headquartered in Tel Aviv, Israel. The listed name for KTOV is Kitov Pharma Ltd. American Depositary Shares.

Employees
Headquarters
Tel Aviv, Tel Aviv
Founded
2010
Market Cap
75.04M
Price-Earnings Ratio
Dividend Yield
Average Volume
343.13K
High Today
$4.49
Low Today
$4.30
Open Price
$4.38
Volume
292.39K
52 Week High
$14.40
52 Week Low
$2.20

Collections

KTOV Earnings

Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
per share
Actual

You May Also Like